<tbody id="grid1_body_tbody"><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_0_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="0" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_0_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="1" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈(166090)</nobr></td><td datatype="" displayformat="" id="grid1_cell_0_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="2" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈-길게 볼수록 좋다<br>ㅁ 3Q23 실적 예상치 하회<br>ㅁ 2024년 실적의 회복세는 높지 않을 것<br>ㅁ 투자의견 Buy, 목표주가 63,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_0_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="3" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="4" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="5" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>49,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_0_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="6" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이베스트투자증권</nobr></td><td id="grid1_cell_0_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="7" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>차용호</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_1_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="8" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_1_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="9" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔에이치엔(181710)</nobr></td><td datatype="" displayformat="" id="grid1_cell_1_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="10" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>NHN-기대할 것이 많은 한 해<br>ㅁ 목표주가 29,000 원으로 커버리지 개시<br>ㅁ 24 년도 영업이익 1,160 억원 예상<br>ㅁ 한국 클라우드 시장 본격 개화</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_1_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="11" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="12" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>29,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="13" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>23,350</nobr></td><td datatype="text" displayformat="" id="grid1_cell_1_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="14" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_1_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="15" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_2_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="16" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_2_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="17" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코미코(183300)</nobr></td><td datatype="" displayformat="" id="grid1_cell_2_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="18" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코미코-디램 노출도 높은 편안한 선택지<br>ㅁ 목표주가 63,000원으로 커버리지 개시<br>ㅁ 높은 디램 노출도에 기인한 실적 개선 가시성 주목<br>ㅁ 자회사 미코세라믹스 편입 시너지 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_2_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="19" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="20" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="21" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,300</nobr></td><td datatype="text" displayformat="" id="grid1_cell_2_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="22" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한화투자증권</nobr></td><td id="grid1_cell_2_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="23" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김광진.최영주</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_3_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="24" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_3_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="25" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서연이화(200880)</nobr></td><td datatype="" displayformat="" id="grid1_cell_3_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="26" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서연이화-3분기 수익성 다시 상승<br>ㅁ 3Q23 Review: 영업이익률 6.3% 기록<br>ㅁ 최근 2년 간 매출액이 65% 성장<br>ㅁ P/E 2배 대에서 거래 중</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_3_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="27" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="28" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="29" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>16,810</nobr></td><td datatype="text" displayformat="" id="grid1_cell_3_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="30" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_3_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="31" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>송선재.안도현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_4_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="32" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_4_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="33" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치엘만도(204320)</nobr></td><td datatype="" displayformat="" id="grid1_cell_4_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="34" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HL만도-“지금 어느 동아줄을 붙잡고 있는가”라고 물을 때 돋보이는 부품사<br>ㅁ 북미 전기차 선도 업체에 대한 EPB (전자파킹브레이크), EPS (파워스티어링) 공급 중. IDB2 공급 예정<br>ㅁ Rivian 등 북미 전기차 스타트업들에도 ADAS 시스템, 센서 등을 공급<br>ㅁ 중국 자동차 내수 시장의 회복으로부터 수혜 가능</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_4_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="35" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="36" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="37" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>34,950</nobr></td><td datatype="text" displayformat="" id="grid1_cell_4_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="38" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>KB증권</nobr></td><td id="grid1_cell_4_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="39" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>강성진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_5_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="40" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_5_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="41" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠(196170)</nobr></td><td datatype="" displayformat="" id="grid1_cell_5_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="42" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠-바빠지고 있다<br>ㅁ 투자의견 BUY 및 목표주가 90,000원으로 상향: 마일스톤 유입으로 인한 이익 창출력을 선반영(도표 1 참고)<br>ㅁ 2024년 초부터 면역항암제 SC제형들 출시 예정: 티센트릭®SC(로슈), 옵디보® SC (BMS) 임상 3상 성공으로<br>ㅁ 2차 계약사와 SC제형 특허권 이전, 2차 CMO 선정 및 확정 등과 관련된 논의가 진행되고 있을 것으로 추정</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_5_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="43" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="44" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>90,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="45" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>72,300</nobr></td><td datatype="text" displayformat="" id="grid1_cell_5_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="46" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_5_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="47" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>권해순</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_6_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="48" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_6_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="49" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>제이앤티씨(204270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_6_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="50" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>제이앤티씨-3Q23 Review: 중국 화웨이향 강화유리, 4분기에도 공급 확대 수혜 기대<br>ㅁ 3Q23 Review: 매출액은 전년동기 대비 168.5% 증가. 영업이익은 전분기에 이어 흑자전환 성공<br>ㅁ 4Q23 Preview: 14분기만에 분기 매출액이 1,000억원대를 돌파하는 것도 긍정적임</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_6_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="51" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="52" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="53" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>13,790</nobr></td><td datatype="text" displayformat="" id="grid1_cell_6_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="54" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_6_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="55" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종선</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_7_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="56" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_7_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="57" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_7_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="58" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-우려를 이겨내는 실적<br>ㅁ 3Q23 review: 의료기기 내수 성장 및 화장품 수출 성장, 홈쇼핑 채널 축소를 통한 판관비 감소로 영업이익 컨센서스 상회.<br>ㅁ 투자의견 BUY, 목표주가 19만원 유지: 리쥬란 브랜드 확장 지속 중이며, 출시 초기국가 중심 매출 상승 기대. 콘쥬란 급여 기준 강화 이슈는 지속 확인 필요.</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_7_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="59" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="60" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>190,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="61" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_7_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="62" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_7_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="63" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동희</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_8_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="64" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_8_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="65" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_8_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="66" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>PharmaResearch-Steady sales growth of medical devices and cosmetics<br>ㅁ 3Q review<br>ㅁ Maintaining BUY and KRW190,000 target</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_8_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="67" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="68" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>190,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="69" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_8_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="70" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_8_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="71" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동희</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_9_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="72" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_9_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="73" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_9_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="74" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-또 역대급 실적, 성장판 많이 열려있다<br>ㅁ 3Q23 매출액 및 영업이익 당사 추정치/컨센서스 상회<br>ㅁ 동사의 성장 동력인 화장품과 의료기기 성장 지속 가능 판단<br>ㅁ 글로벌 국가 확대 및 화장품 신제품 출시 통해 매출 확대 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_9_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="75" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="76" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>180,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="77" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_9_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="78" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_9_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="79" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종현.이정우</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_10_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="80" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_10_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="81" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_10_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="82" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-3Q23 Review: 기대치를 상회하는 영업현황 확인<br>ㅁ 3Q23 Review: 매출액 688억원(+49% yoy), 영업이익 275억원(+66% yoy)<br>ㅁ 수출 국가 확대를 통한 성장에 관심이 높아지는 시점</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_10_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="83" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="84" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>175,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="85" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_10_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="86" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이베스트투자증권</nobr></td><td id="grid1_cell_10_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="87" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>조은애</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_11_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="88" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_11_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="89" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_11_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="90" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-리쥬란브랜드 파워 실적으로 확인<br>ㅁ 3분기 어닝 서프라이즈 실현<br>ㅁ 리쥬란 스킨부스터, 리쥬란 화장품 브랜드 잠재력에 주목한다<br>ㅁ 4분기 영업실적 전망도 긍정적</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_11_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="91" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="92" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>180,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="93" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_11_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="94" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>상상인증권</nobr></td><td id="grid1_cell_11_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="95" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하태기</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_12_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="96" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_12_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="97" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이제이네트웍스(095570)</nobr></td><td datatype="" displayformat="" id="grid1_cell_12_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="98" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>AJ네트웍스-3Q23 Review: 매출 부진에도 불구하고,수익성 개선은 긍정적.<br>ㅁ 3Q23 Review: 매출액은 감소세를 보이나, 수익성은 개선되어 영업이익은 시장 기대치를 상회<br>ㅁ 4Q23 Preview: 전년 동기 수준의 매출액을 예상하지만, 수익성 개선은 지속될 것으로 전망</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_12_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="99" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="100" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>6,500</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="101" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>4,095</nobr></td><td datatype="text" displayformat="" id="grid1_cell_12_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="102" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_12_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="103" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종선</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_13_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="104" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_13_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="105" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이(228670)</nobr></td><td datatype="" displayformat="" id="grid1_cell_13_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="106" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이-예상되었던 부진, 4Q23 실적의 핵심은 미국 시장<br>ㅁ 매출 및 영업이익 모두 시장기대치 하회하는 실적 달성<br>ㅁ 현 주가는 12개월 선행 P/E 16배로 동사의 지난 1년 평균(33배) 및 글로벌 Peer(24배) 대비 저평가</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_13_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="107" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="108" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>32,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="109" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>20,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_13_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="110" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_13_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="111" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김충현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_14_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="112" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_14_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="113" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이(228670)</nobr></td><td datatype="" displayformat="" id="grid1_cell_14_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="114" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Ray-Sluggish 3Q23 results; US market to hold the key in 4Q23<br>ㅁ Revenue and OP miss consensus<br>ㅁ Undervalued at a 12-month forward P/E of 16x vs. one-year average of 33x and global peer average of 24x</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_14_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="115" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="116" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>32,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="117" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>20,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_14_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="118" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Mirae Asset Securiti</nobr></td><td id="grid1_cell_14_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="119" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김충현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_15_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="120" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_15_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="121" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치케이이노엔(195940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_15_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="122" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HK이노엔-2024년에도 지속되는 성장 스토리<br>ㅁ 투자의견 BUY 및 목표주가 50,000원으로 신규 제시<br>ㅁ 2024년 주가 Catalysts: 케이캡® 국내 및 글로벌 판매 수익 증가, 미국 임상 완료<br>ㅁ Phathom Pharmaceuticals(NASDAQ: PHAT)의 보？자®(다케다 보노프라잔 미국 브랜드) FDA 승인(10월 30일)</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_15_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="123" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="124" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>50,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="125" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,050</nobr></td><td datatype="text" displayformat="" id="grid1_cell_15_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="126" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_15_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="127" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>권해순</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_16_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="128" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_16_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="129" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>화승엔터프라이즈(241590)</nobr></td><td datatype="" displayformat="" id="grid1_cell_16_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="130" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>화승엔터프라이즈-3Q23 Review: 재고 부담<br>ㅁ 3Q23 가동률 저하 <br>ㅁ 투자의견 Buy 및 적정주가 10,000원 제시</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_16_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="131" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="132" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>10,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="133" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>7,980</nobr></td><td datatype="text" displayformat="" id="grid1_cell_16_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="134" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>메리츠증권</nobr></td><td id="grid1_cell_16_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="135" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하누리</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_17_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="136" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_17_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="137" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>화승엔터프라이즈(241590)</nobr></td><td datatype="" displayformat="" id="grid1_cell_17_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="138" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>화승엔터프라이즈-2024년 스포츠 빅이벤트  앞두고 재고 조정 막바지<br>ㅁ 3분기에도 가동율 80% 초중반으로 부진<br>ㅁ 고객사 재고 조정은 기대 이상으로 빠르게 진행<br>ㅁ 10월 가동율 완만히 회복. 2024년 스포츠 빅이벤트 앞두고 수주 회복 예상</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_17_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="139" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="140" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>14,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="141" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>7,980</nobr></td><td datatype="text" displayformat="" id="grid1_cell_17_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="142" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_17_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="143" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유정현.정한솔</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_18_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="144" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_18_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="145" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>피엔에이치테크(239890)</nobr></td><td datatype="" displayformat="" id="grid1_cell_18_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="146" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>피엔에이치테크-본격적인 OLED 확대 시작<br>ㅁ 3Q23 영업이익 21억원(+133% QoQ) 기록 <br>ㅁ 4분기 영업이익 27억원(+33% QoQ) 전망 <br>ㅁ IT OLED 소재 구성 협의가 진행될 2023년 연말에 주목 <br>ㅁ IT OLED 확대에 따른 이중 수혜 + 차량용 OLED 확대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_18_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="147" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="148" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>31,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="149" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>23,400</nobr></td><td datatype="text" displayformat="" id="grid1_cell_18_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="150" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_18_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="151" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>남궁현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_19_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="152" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_19_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="153" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서진시스템(178320)</nobr></td><td datatype="" displayformat="" id="grid1_cell_19_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="154" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서진시스템-3Q23 Review: 4분기부터 전 사업, 본격적인 실적 성장 기대<br>ㅁ 3Q23 Review: 시장 기대치 하회했으나, 지난해 4분기부터 전기차 부품 사업 성장세 유지<br>ㅁ 4Q23 Preview: 베트남 박닌, 박장 공장은 물론 임대 공장까지 가동, 전 사업 부문 높은 실적 성장세 예상</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_19_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="155" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="156" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>22,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="157" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>18,400</nobr></td><td datatype="text" displayformat="" id="grid1_cell_19_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="158" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_19_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="159" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종선</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_20_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="160" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_20_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="161" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블(251270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_20_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="162" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블-오버행만으로 안보긴 아깝다<br>ㅁ 목표주가 65,000 원으로 커버리지 개시. 게임 Top Pick 으로 제시<br>ㅁ &lt;나 혼자만 레벨업&gt;의 해외 인지도는 상상 이상<br>ㅁ AI 수혜는 클 것</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_20_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="163" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="164" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>65,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="165" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,200</nobr></td><td datatype="text" displayformat="" id="grid1_cell_20_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="166" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_20_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="167" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_21_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="168" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_21_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="169" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>크래프톤(259960)</nobr></td><td datatype="" displayformat="" id="grid1_cell_21_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="170" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>크래프톤-기다리던 신작이 온다<br>ㅁ 24년 영업이익 6,773억원으로 예상<br>ㅁ 신작 가뭄은 끝나고 24년을 기점으로 글로벌 대작 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_21_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="171" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="172" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>240,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="173" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>204,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_21_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="174" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_21_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="175" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_22_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="176" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_22_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="177" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신흥에스이씨(243840)</nobr></td><td datatype="" displayformat="" id="grid1_cell_22_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="178" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신흥에스이씨-지나친 소외<br>ㅁ 3분기 실적, 당사 예상치에 부합<br>ㅁ 4분기 고객사 재고조정 영향이 있으나 24년 20%대 성장 유효</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_22_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="179" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="180" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>55,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="181" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>41,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_22_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="182" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_22_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="183" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>장정훈</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_23_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="184" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_23_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="185" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신흥에스이씨(243840)</nobr></td><td datatype="" displayformat="" id="grid1_cell_23_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="186" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>SHINHEUNG SEC-Shares have been sidelined for too long<br>ㅁ 3Q results in line<br>ㅁ 4Q results to take a hit from clients’ inventory adjustment; sales to grow more than 20% y-y in 2024</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_23_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="187" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="188" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>55,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="189" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>41,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_23_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="190" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_23_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="191" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>장정훈</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_24_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="192" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_24_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="193" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>디앤씨미디어(263720)</nobr></td><td datatype="" displayformat="" id="grid1_cell_24_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="194" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>디앤씨미디어-글로벌IP가 있다는 것<br>ㅁ 24년 영업이익 144억원으로 예상<br>ㅁ 본업도 이상무</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_24_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="195" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="196" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>29,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="197" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>22,850</nobr></td><td datatype="text" displayformat="" id="grid1_cell_24_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="198" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_24_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="199" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_25_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="200" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_25_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="201" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>케이씨텍(281820)</nobr></td><td datatype="" displayformat="" id="grid1_cell_25_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="202" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>케이씨텍-HBM까지 아우른다<br>ㅁ CMP 공정 장비·소재사<br>ㅁ HBM까지 아우른다<br>ㅁ 투자의견 Buy, 목표주가 27,000원으로 커버리지 개시</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_25_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="203" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="204" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>27,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="205" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>22,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_25_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="206" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>DB금융투자</nobr></td><td id="grid1_cell_25_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="207" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서승연</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_26_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="208" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_26_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="209" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치디씨현대산업개발(294870)</nobr></td><td datatype="" displayformat="" id="grid1_cell_26_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="210" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HDC현대산업개발-바닥 짚고 일어나는 중<br>ㅁ 2024년 광운대 역세권으로 자체사업 재시동<br>ㅁ 전화위복<br>ㅁ 커버리지 재개, 투자의견 매수, 목표주가 18,000원</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_26_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="211" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="212" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>18,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="213" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>13,360</nobr></td><td datatype="text" displayformat="" id="grid1_cell_26_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="214" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신영증권</nobr></td><td id="grid1_cell_26_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="215" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박세라</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_27_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="216" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_27_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="217" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오게임즈(293490)</nobr></td><td datatype="" displayformat="" id="grid1_cell_27_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="218" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오게임즈-PC 신작을 기다리며<br>ㅁ 24년 영업이익 1,540억원으로 예상<br>ㅁ 본격적인 성장은 PC 신작이 반응하면</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_27_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="219" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="220" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>33,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="221" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>25,550</nobr></td><td datatype="text" displayformat="" id="grid1_cell_27_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="222" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_27_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="223" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_28_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="224" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_28_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="225" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엘앤씨바이오(290650)</nobr></td><td datatype="" displayformat="" id="grid1_cell_28_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="226" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엘앤씨바이오-3Q23 Re: 메가카티 매출액 35억원<br>ㅁ 3Q23 Re: 또 한번 분기 최고 매출액 경신<br>ㅁ 중국 진출 계획도 이상 무<br>ㅁ 2023년 매출액 716억원, 영업이익 116억원 전망</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_28_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="227" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="228" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="229" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>34,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_28_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="230" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_28_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="231" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김규상</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_29_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="232" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_29_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="233" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엘앤씨바이오(290650)</nobr></td><td datatype="" displayformat="" id="grid1_cell_29_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="234" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엘앤씨바이오-메가카티 효과 확인한 3Q<br>ㅁ 역대 최대 실적 달성한 3Q<br>ㅁ 확인해야 할 두 가지 이슈</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_29_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="235" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="236" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="237" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>34,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_29_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="238" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>IBK투자증권</nobr></td><td id="grid1_cell_29_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="239" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이건재</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255); display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_30_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="240" or_wd="100" style_bak="text-align:center;height:20px" or_bgcolor=""></td><td datatype="text" id="grid1_cell_30_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="241" or_wd="140" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="" displayformat="" id="grid1_cell_30_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="242" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatyp="text" displayformat="" id="grid1_cell_30_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="243" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="244" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="245" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="text" displayformat="" id="grid1_cell_30_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="246" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td id="grid1_cell_30_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="247" or_wd="50" style_bak="text-align:left;height:20px" or_bgcolor=""></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_31_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="248" or_wd="100"></td><td datatype="text" id="grid1_cell_31_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="249" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_31_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="250" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_31_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="251" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="252" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="253" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_31_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="254" or_wd="100"></td><td id="grid1_cell_31_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="255" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_32_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="256" or_wd="100"></td><td datatype="text" id="grid1_cell_32_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="257" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_32_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="258" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_32_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="259" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="260" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="261" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_32_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="262" or_wd="100"></td><td id="grid1_cell_32_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="263" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_33_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="264" or_wd="100"></td><td datatype="text" id="grid1_cell_33_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="265" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_33_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="266" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_33_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="267" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="268" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="269" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_33_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="270" or_wd="100"></td><td id="grid1_cell_33_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="271" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_34_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="272" or_wd="100"></td><td datatype="text" id="grid1_cell_34_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="273" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_34_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="274" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_34_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="275" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="276" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="277" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_34_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="278" or_wd="100"></td><td id="grid1_cell_34_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="279" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_35_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="280" or_wd="100"></td><td datatype="text" id="grid1_cell_35_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="281" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_35_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="282" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_35_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="283" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="284" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="285" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_35_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="286" or_wd="100"></td><td id="grid1_cell_35_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="287" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_36_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="288" or_wd="100"></td><td datatype="text" id="grid1_cell_36_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="289" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_36_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="290" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_36_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="291" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="292" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="293" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_36_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="294" or_wd="100"></td><td id="grid1_cell_36_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="295" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_37_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="296" or_wd="100"></td><td datatype="text" id="grid1_cell_37_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="297" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_37_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="298" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_37_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="299" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="300" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="301" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_37_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="302" or_wd="100"></td><td id="grid1_cell_37_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="303" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_38_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="304" or_wd="100"></td><td datatype="text" id="grid1_cell_38_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="305" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_38_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="306" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_38_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="307" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="308" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="309" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_38_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="310" or_wd="100"></td><td id="grid1_cell_38_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="311" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_39_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="312" or_wd="100"></td><td datatype="text" id="grid1_cell_39_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="313" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_39_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="314" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_39_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="315" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="316" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="317" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_39_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="318" or_wd="100"></td><td id="grid1_cell_39_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="319" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_40_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="320" or_wd="100"></td><td datatype="text" id="grid1_cell_40_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="321" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_40_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="322" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_40_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="323" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="324" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="325" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_40_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="326" or_wd="100"></td><td id="grid1_cell_40_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="327" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_41_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="328" or_wd="100"></td><td datatype="text" id="grid1_cell_41_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="329" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_41_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="330" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_41_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="331" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="332" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="333" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_41_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="334" or_wd="100"></td><td id="grid1_cell_41_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="335" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_42_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="336" or_wd="100"></td><td datatype="text" id="grid1_cell_42_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="337" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_42_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="338" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_42_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="339" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="340" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="341" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_42_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="342" or_wd="100"></td><td id="grid1_cell_42_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="343" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_43_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="344" or_wd="100"></td><td datatype="text" id="grid1_cell_43_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="345" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_43_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="346" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_43_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="347" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="348" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="349" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_43_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="350" or_wd="100"></td><td id="grid1_cell_43_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="351" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_44_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="352" or_wd="100"></td><td datatype="text" id="grid1_cell_44_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="353" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_44_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="354" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_44_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="355" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="356" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="357" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_44_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="358" or_wd="100"></td><td id="grid1_cell_44_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="359" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_45_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="360" or_wd="100"></td><td datatype="text" id="grid1_cell_45_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="361" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_45_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="362" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_45_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="363" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="364" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="365" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_45_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="366" or_wd="100"></td><td id="grid1_cell_45_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="367" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_46_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="368" or_wd="100"></td><td datatype="text" id="grid1_cell_46_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="369" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_46_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="370" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_46_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="371" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="372" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="373" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_46_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="374" or_wd="100"></td><td id="grid1_cell_46_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="375" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_47_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="376" or_wd="100"></td><td datatype="text" id="grid1_cell_47_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="377" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_47_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="378" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_47_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="379" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="380" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="381" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_47_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="382" or_wd="100"></td><td id="grid1_cell_47_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="383" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_48_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="384" or_wd="100"></td><td datatype="text" id="grid1_cell_48_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="385" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_48_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="386" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_48_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="387" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="388" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="389" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_48_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="390" or_wd="100"></td><td id="grid1_cell_48_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="391" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_49_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="392" or_wd="100"></td><td datatype="text" id="grid1_cell_49_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="393" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_49_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="394" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_49_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="395" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="396" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="397" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_49_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="398" or_wd="100"></td><td id="grid1_cell_49_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="399" or_wd="50"></td></tr></tbody>